Search All Jobs
Showing 1 of 1 Jobs
Full-Time
Mendaera
51-200 employees
Develops technology for efficient healthcare delivery
Compensation Overview
$119k - $179k/yr
Senior
San Mateo, CA, USA
Upload your resume to see how it matches 13 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- Advanced technical degree and at least 5+ years industry experience
- Excellent technical and analytical capability, with strong written and verbal communication skills
- High level of emotional intelligence and ability to build and manage diverse relationships
- Proficiency in at least one higher level programming language (C++, Python, etc.)
- Knowledge of medical device software standards: IEC 62304 and ISO 14971
- Applied experience testing native applications and hardware
- Work with the product and engineering teams to develop innovative and effective test workflows, systems and procedures for measuring and improving overall software quality
- Create and automate tests for Mendaera products
- Drive functional, regression, integration, and end-to-end testing
- File bug reports and work with engineers and product management to drive issues to conclusion
- Build new automated test frameworks and enhance existing ones
- Create and manage software requirements under medical device standards and regulations
- Document Software Verification Protocols and test results using the Quality Management System
- Entrepreneurial, self-motivated, and independent
- Versatility and ability to operate in a small-team environment
- Experience with JIRA or any similar defect tracking tool
- Experience with Jama or any similar requirements management tool
- Experience with ROS and/or firm real-time systems a plus
Mendaera provides advanced technology solutions that improve point-of-care interventions in healthcare. Their products enable healthcare providers to perform medical procedures accurately at the patient's location, eliminating the need for patient transfers. Mendaera differentiates itself by focusing on enhancing efficiency and effectiveness for hospitals, clinics, and individual practitioners while ensuring regulatory compliance. The company's goal is to transform healthcare delivery, reduce costs, and improve patient outcomes.
Company Size
51-200
Company Stage
Series B
Total Funding
$97M
Headquarters
San Carlos, California
Founded
2020
Simplify's Take
What believers are saying
- $73M Series B funding accelerates robotics and AI technology development and market penetration.
- Eric Davidson's appointment as CCO enhances strategic growth and partnership opportunities.
- Support from Dr. Fred Moll provides industry insights and credibility for regulatory approvals.
What critics are saying
- Integration of Avail's telepresence tech may delay product rollouts or affect quality.
- Reliance on venture capital funding pressures Mendaera for quick returns, risking strategic missteps.
- Rapid AI and robotics advancements may outpace Mendaera's ability to keep up, risking obsolescence.
What makes Mendaera unique
- Mendaera integrates robotics, AI, and real-time imaging for precise point-of-care interventions.
- The company collaborates with EchoNous to enhance ultrasound-guided interventional procedures.
- Mendaera's acquisition of Avail Medsystems' telepresence technology boosts remote healthcare capabilities.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Professional Development Budget
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↑ 9%2 year growth
↓ -3%Mendaera appoints medical robotics leader Eric Davidson as Chief Commercial Officer.
Mendaera has secured $73M in venture capital to advance its handheld robotics platform for needle-based procedures like biopsy and vascular access. The Silicon Valley startup aims to address healthcare provider shortages and rising demand by integrating real-time imaging with robotic guidance. The Series B funding was led by Threshold Ventures, with participation from Lux Capital and others, to enhance patient care and expand access to high-quality medical procedures.
Portable ultrasound company EchoNous and AI and robotics company Mendaera have established a commercial partnership to develop new ultrasound-guided technology for interventional procedures.
Mediwhale, an AI-powered health diagnostics company, raised $12 million in Series A2 funding led by Korea Development Bank, with participation from Woori Venture Partners, IMM Investment, and Mirae Asset Securities. The funds will enhance AI algorithms, seek U.S. FDA approval for Reti-CVD, expand globally, and develop new products. Movement Labs' partners raised $13.2 million, Tetrix secured $5 million, and Bot Auto raised $20 million in their respective funding rounds.
Mendaera announced $73 million Series B funding round led by Threshold Ventures to scale robotics and AI across mainstream medical procedures.